Who gets the weight loss drugs when supply doesn’t meet demand? episode artwork

EPISODE · Nov 18, 2023 · 26 MIN

Who gets the weight loss drugs when supply doesn’t meet demand?

from Reuters World News · host Reuters

A revolutionary new class of drugs is transforming weight loss. But around the world, demand is skyrocketing for diabetes drugs because they also help people shed pounds. Join our global health journalists as we explore access to drugs like Wegovy and Ozempic and the transformation of the way we understand weight loss. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Nov 18, 2023

Embed this episode

NOW PLAYING

Who gets the weight loss drugs when supply doesn’t meet demand?

0:00 26:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Reuters World News?

This episode is 26 minutes long.

When was this Reuters World News episode published?

This episode was published on November 18, 2023.

Can I download this Reuters World News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!